Analystreport

Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citigroup Inc. to an "outperform" rating.

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report